Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan · Delayed Price · Currency is TWD 51.50
-1.60 (-3.01%)
Feb 11, 2026, 1:30 PM CST
Senhwa Biosciences Market Cap
Senhwa Biosciences has a market cap or net worth of 4.74 billion as of February 10, 2026. Its market cap has increased by 25.98% in one year.
Market Cap
4.74B
Enterprise Value
3.93B
Revenue
1.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
51.50
Market Cap Chart
Since December 4, 2014, Senhwa Biosciences's market cap has decreased from 6.81B to 4.74B, a decrease of -30.47%. That is a compound annual growth rate of -3.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 4.74B | 20.68% |
| Dec 31, 2025 | 3.92B | 1.15% |
| Dec 31, 2024 | 3.88B | -14.54% |
| Dec 29, 2023 | 4.54B | -11.69% |
| Dec 30, 2022 | 5.14B | -44.90% |
| Dec 30, 2021 | 9.33B | -53.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 5.76B |
| Locus Cell | 5.51B |
| Pharmosa Biopharm | 5.41B |
| Panion & Bf Biotech | 5.30B |
| UnicoCell Biomed | 5.26B |
| Steminent Biotherapeutics | 5.26B |
| AnnJi Pharmaceutical | 4.69B |
| BioGend Therapeutics | 4.53B |